Intelligent medical platform wins intl award

CybeRay Pro, an intelligent non‑invasive radiosurgery platform developed by Xi'an's OUR United Co, has made the list of the year's most innovative commercial technologies of the 2026 R&D 100 Awards.

Launched in 1963, the R&D 100 Awards recognize significant new products, technologies, and materials with commercial value. The awards are highly prestigious in science and technology innovation and are known as the "Oscars of technological innovation".

OUR United's winning technology marks the first‑ever selection for a Chinese large‑scale medical device, representing a historic breakthrough for China's high‑end medical equipment industry.

As a global leader in intelligent radiosurgery solutions and a pioneer in integrated X/γ‑ray radiotherapy technology, the company has established its North American R&D Center in San Francisco. It is also steadily advancing the construction of regional bases across Southeast Asia, Europe, and the Middle East to build a global service system covering major and emerging markets.

CybeRay Pro is the world's first real‑time image‑guided gamma radiosurgery system cleared by the US FDA. Integrating intra‑fraction image guidance, dynamic non‑coplanar arc delivery, and AI‑powered intelligent workflow, it delivers sub‑millimeter precise ablation treatment for lesions across all body parts.

Through more than a decade of growth and independent innovation, the company blazed a trail for originated high‑end medical equipment in China. The accolade not only marks that the company has fostered core competitiveness in underlying technology and market standing within gamma‑ray radiotherapy, but also proves that China's high‑end medical equipment is among the world's most innovative technologies.